On December 1st, 2008 Johnson & Johnson (JNJ) announced a 1.1 billion dollar deal to acquire breast implant and aesthetic specialties supplier, Mentor corporation (MNT).
During the recent economic turmoil, Mentor has been focused on boosting sales of its silicone implant line, which has actually experienced great success since the FDA lifted its 14-year ban on them two years ago.
In related news, Mentor is expected to receive FDA approval of its botulinum toxin-derived injectable around mid 2010 and it should allow them to compete directly with the pharmaceuticals giant Allergan Inc, who manufactures the popular injectable, Botox.
